However, since CD133 is preferentially expressed in specific cells, such as neural and hematopoietic stem cells and cancer stem cells, the endosomal CD133-mediated inhibition of autophagy may only occur in specialized cells, and not in all cell types. This evidence concerns the gene PROM1 and cancer.